AdaptHealth (NASDAQ:AHCO) Price Target Cut to $13.00 by Analysts at Truist Financial

AdaptHealth (NASDAQ:AHCO - Free Report) had its price target trimmed by Truist Financial from $14.00 to $13.00 in a research report report published on Monday,Benzinga reports. The firm currently has a buy rating on the stock.

A number of other equities research analysts also recently commented on the company. Robert W. Baird upped their price objective on AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a report on Thursday, February 27th. Royal Bank of Canada cut their price target on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a report on Thursday, May 8th. UBS Group reduced their target price on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a report on Thursday, February 13th. Finally, Canaccord Genuity Group boosted their price target on AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus target price of $13.40.

AdaptHealth Trading Down 0.1%

AdaptHealth stock traded down $0.01 during trading hours on Monday, reaching $8.89. 78,978 shares of the company's stock traded hands, compared to its average volume of 1,568,865. AdaptHealth has a fifty-two week low of $7.11 and a fifty-two week high of $11.90. The firm's 50 day moving average is $9.19 and its 200-day moving average is $9.71. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The firm has a market capitalization of $1.20 billion, a price-to-earnings ratio of -5.39, a PEG ratio of 1.08 and a beta of 1.64.

Institutional Investors Weigh In On AdaptHealth

A number of large investors have recently bought and sold shares of AHCO. Assetmark Inc. acquired a new position in AdaptHealth during the 4th quarter worth approximately $28,000. Blue Trust Inc. increased its position in shares of AdaptHealth by 24.1% during the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock worth $55,000 after buying an additional 1,115 shares during the period. GAMMA Investing LLC raised its position in shares of AdaptHealth by 175.2% in the 1st quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock worth $81,000 after acquiring an additional 4,758 shares in the last quarter. Brooklyn Investment Group lifted its position in shares of AdaptHealth by 531.8% during the 1st quarter. Brooklyn Investment Group now owns 7,563 shares of the company's stock valued at $82,000 after acquiring an additional 6,366 shares during the period. Finally, Y Intercept Hong Kong Ltd bought a new stake in AdaptHealth in the 1st quarter valued at about $114,000. 82.67% of the stock is currently owned by institutional investors and hedge funds.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.